PCC SE confirms Dr. Peter Wenzel as Chairman of the Executive Board until 2031

Key highlights
  • The Supervisory Board appointed Dr. Peter Wenzel on May 8, 2026.
  • His new mandate runs until May 7, 2031, a five-year term.
  • The decision underscores PCC SE’s orientation as a long-term investor.
  • Company positions the continuity as a source of stability, experience and sustainable corporate development in a challenging market.

Appointment

The Supervisory Board has appointed Dr. Peter Wenzel as Chairman of the Executive Board at its meeting on May 8, 2026. The new mandate runs until May 7, 2031.

Strategic rationale

With this decision, PCC SE underscores its orientation as a long-term oriented investor. Especially in the currently challenging market environment, this continuity at the top of the company stands for stability, experience and a consistent and sustainable corporate development.

Source: PCC SE

chemXplore 2026 industry outlook